Viewing nowPiarizon Tablets 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200707542 · Approved 2007.06.29 · Insurance code 643503900
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapies to help control blood sugar levels in patients with type 2 diabetes. It can be administered as monotherapy and can be combined with sulfonylureas, metformin, or insulin if there is no improvement in blood sugar levels from other oral antidiabetic agents. For patients with type 2 diabetes, medication therapy, nutritional counseling, weight loss, and regular exercise are crucial. These efforts greatly aid in both initial treatment and sustaining the effects of the medication. Therefore, this medication is used to improve blood sugar control.
This medicine is administered orally once daily, regardless of meals. Monotherapy may be initiated at 15 mg once daily; if the response is inadequate, the dose may be increased to 30 mg once daily. For combination therapy with a sulfonylurea, metformin, or insulin, administer 15 mg once daily. The maximum recommended dose is 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.
This medication helps control blood sugar levels in patients with type 2 diabetes. However, it can burden the heart in some patients; thus, it should not be used in patients with heart failure or a history of heart failure. If symptoms of heart failure such as sudden weight gain, shortness of breath, or swelling occur while taking this medication, a doctor's examination must be sought immediately. Additionally, this medication can cause fluid retention and worsen heart failure, so caution is needed for patients with heart conditions. It should not be given to patients with bladder cancer or a history of bladder cancer, and if urinary disorders or hematuria occur, the doctor should be informed immediately. It is also advisable for patients with poor liver function or severe kidney disease to avoid using this medication. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women are advised to use appropriate contraception as the risk of pregnancy may increase while on this medication. This medication is only for patients with insulin resistance and is not suitable for patients with type 1 diabetes or diabetic ketoacidosis. Regular blood sugar and liver function tests should be performed while on this medication, and any abnormal symptoms should be consulted with a doctor immediately. Also, the risk of hypoglycemia may increase when combined with other antidiabetic agents, so caution is required. Common side effects include swelling, weight gain, headache, and upper respiratory infections, and in severe cases, symptoms of heart failure may appear. If sudden swelling or shortness of breath occurs while taking this medication, healthcare professionals should be informed immediately. There may not be any specific symptoms of overdose, but if suspected, prompt medical attention should be sought. This medication has not been proven safe and effective for children and should be used cautiously in the elderly. Store in a place out of children's reach and keep in the original container tightly closed.
Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, inadequate blood glucose control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distention, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, hospitalization due to exacerbation of congestive heart failure, emergency room visit due to congestive heart failure, cardiovascular abnormalities, liver failure, diabetic macular edema with decreased vision, elevated serum ALT levels, elevated serum AST, elevated serum ALP, elevated serum bilirubin, decreased hemoglobin, decreased hematocrit, increased serum creatinine, dizziness, appetite loss, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremor, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle rigidity, discomfort in the head, worsening of liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a special container to protect it from light and air, avoiding humid areas, and kept at a cool temperature between 15 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.
White to slightly cloudy white, round, and convex tablets
1 bottle/box [30 tablets/bottle], 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.